Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Index levels matter because they summarize broader market dynamics. This snippet covers why they matter and how traders can incorporate them.
27,318 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
A six-story glass building in Manhattan's Chinatown sits at the center of a courtroom fight over whether it was a cov...
Roadrunner, the AI-powered CPQ startup, today disclosed a $27 million funding round led by Kleiner Perkins and FOUNDE...
Forget intel. executives cashing has raised caution among traders, but the AI demand backdrop remains intact. This pi...
As storms loom and costs climb, homeowners need more than a mortgage. This report examines resilience financing, insu...
As Okta gears up for 2027 earnings, investors weigh big growth bets against profitability hurdles. This guide breaks ...
A high-profile CEO champions self-taught, AI-fluent leadership while leaning on a deep bench of scientists. The piece...
When celebrities make their relationship public, it isn’t just headlines that change. Janel Parrish Sasha Farber prov...
When the Doctor Who 2026 Christmas special was canceled, fans faced more than a calendar change. This article transla...
When energy costs rise, investors often look for EV players that could benefit. This article unpack Rivian's path to ...
From a memoir announcement to a heartfelt birthday tribute, this guide turns a focal family moment into actionable fi...
RMDs can be a sneaky drain on retirement income if mismanaged. This article highlights the costliest mistakes retiree...